Cedric Ververken

The preclinical pharmacology of the high affinity anti-IL-6R Nanobody® ALX-0061 supports its clinical development in rheumatoid arthritis

Maarten Van Roy, Cedric Ververken, Els Beirnaert et al. · Arthritis Research & Therapy · 2015 · 176 citations · Full text

Inflammation, Rheumatology, Rheumatoid Disorder +10

Stimulatory effect of CpG sequences on humoral response in chickens

B. Vleugels, Cedric Ververken, Bruno Goddeeris · Poultry Science · 2002 · 63 citations · Full text

Veterinary Vaccine, Engineering, Genetics +18

Anti‐c‐<scp>MET</scp> Nanobody^® – a new potential drug in multiple myeloma treatment

Tobias S. Slørdahl, Tinneke Denayer, Siv Helen Moen et al. · European Journal Of Haematology · 2013 · 44 citations · Full text

FAS inhibitor cerulenin reduces food intake and melanocortin receptor gene expression without modulating the other (an)orexigenic neuropeptides in chickens

Sami Dridi, Cedric Ververken, F. Bradley Hillgartner et al. · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · 2006 · 41 citations

Nutrition, Orexigenic Neuropeptides, Food Intake +25

VHH antibody targeting the chemokine receptor CX3CR1 inhibits progression of atherosclerosis

Sarah Löw, Haixia Wu, Kavita Jerath et al. · mAbs · 2020 · 35 citations · Full text

Vascular Disease, Plaque Progression, Immunology +20